Interaction of the COOH-terminal transactivation domain of p65 NF-kappa B with TATA-binding protein, transcription factor IIB, and coactivators
about
Inhibition of nuclear factor-kappaB-mediated transcription by association with the amino-terminal enhancer of split, a Groucho-related protein lacking WD40 repeatsRING finger protein AO7 supports NF-kappaB-mediated transcription by interacting with the transactivation domain of the p65 subunitCTF5--a new transcriptional activator of the NFI/CTF familyInvolvement of TFIID and USA components in transcriptional activation of the human immunodeficiency virus promoter by NF-kappaB and Sp1.The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factorStimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neuronsThe glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domainA requirement for nuclear factor-kappaB in developmental and plasticity-associated synaptogenesisInhibition of c-Jun NH2-terminal kinase or extracellular signal-regulated kinase improves lung injuryA novel mammalian expression system derived from components coordinating nicotine degradation in arthrobacter nicotinovorans pAO1.Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB.ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kappaBThe enzymatic and DNA binding activity of PARP-1 are not required for NF-kappa B coactivator functionInvolvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B p65-mediated transcription as a coactivatorBcl3, an IkappaB protein, as a novel transcription coactivator of the retinoid X receptorMutual transcriptional interference between RelA and androgen receptorCentrosomal P4.1-associated protein is a new member of transcriptional coactivators for nuclear factor-kappaBUncoupling of Pyrin-only protein 2 (POP2)-mediated dual regulation of NF-κB and the inflammasomeNovel Nuclear Factor-KappaB Targeting Peptide Suppresses β-Amyloid Induced Inflammatory and Apoptotic Responses in Neuronal CellsActivation of transcription factor NF-kappaB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathwaysIdentification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells.Modification of RelA by O-linked N-acetylglucosamine links glucose metabolism to NF-κB acetylation and transcription.The p65 subunit of NF-κB inhibits COL1A1 gene transcription in human dermal and scleroderma fibroblasts through its recruitment on promoter by protein interaction with transcriptional activators (c-Krox, Sp1, and Sp3).Activation of c-myc promoter P1 by immunoglobulin kappa gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs kappaB, E box 1 and E box 2, and of the 3' enhancer motif PU.Muscle precursor cells isolated from aged rats exhibit an increased tumor necrosis factor- alpha responseGlucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivationPyrin-only protein 2 limits inflammation but improves protection against bacteria.Mapping of a serine-rich domain essential for the transcriptional, antiapoptotic, and transforming activities of the v-Rel oncoprotein.Interaction of transactive response DNA binding protein 43 with nuclear factor κB in mild cognitive impairment with episodic memory deficits.Structural characterization of interactions between transactivation domain 1 of the p65 subunit of NF-κB and transcription regulatory factors.NF-κB addiction and its role in cancer: 'one size does not fit all'.Interplay of Rad51 with NF-κB pathway stimulates expression of HIV-1.Involvement of RNA Polymerase III in Immune Responses.Novel p65 binding glucocorticoid-induced leucine zipper peptide suppresses experimental autoimmune encephalomyelitisGlucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cellRepression of the luteinizing hormone receptor gene promoter by cross talk among EAR3/COUP-TFI, Sp1/Sp3, and TFIIBBudesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin 1beta-induced DNA binding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epidermal keratinocytes.Importance of acidic, proline/serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: generation of transdominant-negative mutants.The DEAD-Box RNA Helicase DDX3 Interacts with NF-κB Subunit p65 and Suppresses p65-Mediated TranscriptionInterferon regulatory factors and TFIIB cooperatively regulate interferon-responsive promoter activity in vivo and in vitro
P2860
Q22011204-5883B94B-107C-4CD2-A858-FD3573D1CB34Q24301876-7CDABDF2-467A-4467-88DB-BD673BE4C736Q24313137-B451E4DA-E799-4707-84FD-A2D794161731Q24522478-5D053B3D-ABDA-4400-8098-7E9BE0A830E0Q24563111-C7CCD9CB-2751-4769-ABAC-C6CA5E55287BQ24563145-A1B1E327-1D87-48B0-9451-3162971CA69BQ24600925-01702A4B-60F1-42BD-97CD-5F4F2F3B889EQ24615147-B175507B-91C9-4453-B425-66EDA059B882Q24808687-B10383FB-02A1-4FC5-ACD6-F6E4F97309F5Q24816289-0EF58571-5CA8-4051-A52B-0C5B820EC4A5Q28118359-4A2A46CA-9536-4646-8459-9F3BE3398AA9Q28144441-1F71EBC2-F765-46CA-BC12-7AA11EF73F68Q28190711-07E7B300-71B6-444D-8994-AD245EFA57AEQ28208385-879DCACB-A2BF-4557-B12C-53E9269A7A80Q28288617-E2489F14-559F-43FD-8BCB-9D2C5A665CB6Q28289361-FA50C052-B885-43B9-B7C8-0935D85C0F78Q28305448-449EB109-C4F9-41FC-8E95-D3ADC797C1ACQ28393834-081EB87F-2B3C-4D8A-93E2-BCFB6830C2D5Q28597074-F79D620A-F93C-48E2-BBC7-6456EF9BB5A1Q28611453-9FFCC8A2-813A-4CEC-863B-A3ED33DE6942Q30312189-C4D7444D-0A28-49EC-BE2F-0E46DB27E1F5Q30419967-8F4D0635-C353-4163-98DB-32C4DAA4CEFCQ30504585-C3FC0640-AE7C-4188-BB0C-ECF6902EE816Q33613910-CC6E5F4E-2ECA-4D89-9C4E-ED798D9C8DA0Q33648473-F0331428-F7B0-4E41-802E-E09F1DF89274Q33708904-FA39D588-835F-41F9-9081-F7B0114B5642Q33908383-421598A1-85E1-4BF9-878C-F8400EDC2028Q33957101-4B5FAAB2-3197-4444-9C98-34ECB9353FC9Q34504310-5034D977-43E1-4BE9-8E7E-539CCCB804F2Q34553972-AD45507E-1166-4A62-A343-C36B041F15BBQ35120893-659C7FB2-D3D1-4271-BCF6-0822ED6A8E2EQ35171923-DD4F0607-ED31-4654-A1E5-6665B1F7F81DQ35516643-DB4EEE42-7412-4985-B0EC-4B67F8930998Q35639706-03AC9A52-417C-448A-90A5-CB486F215614Q35666145-DE50C9B2-7120-4F4D-A434-AC7DA8D12F8AQ35923946-1D08DCF1-B2F2-44CC-92FA-670B1FF3AA81Q36012290-AC8E28B6-98FF-41D1-9033-C08CE94DDC71Q36048657-9750811D-1815-48DA-B7F9-2CD6A52E1AADQ36162844-851F5B45-7C12-498F-8853-66DEE9998EC4Q36563655-69290602-0D57-436A-8C71-F4C34CC03DA4
P2860
Interaction of the COOH-terminal transactivation domain of p65 NF-kappa B with TATA-binding protein, transcription factor IIB, and coactivators
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Interaction of the COOH-termin ...... n factor IIB, and coactivators
@ast
Interaction of the COOH-termin ...... n factor IIB, and coactivators
@en
Interaction of the COOH-termin ...... n factor IIB, and coactivators
@nl
type
label
Interaction of the COOH-termin ...... n factor IIB, and coactivators
@ast
Interaction of the COOH-termin ...... n factor IIB, and coactivators
@en
Interaction of the COOH-termin ...... n factor IIB, and coactivators
@nl
prefLabel
Interaction of the COOH-termin ...... n factor IIB, and coactivators
@ast
Interaction of the COOH-termin ...... n factor IIB, and coactivators
@en
Interaction of the COOH-termin ...... n factor IIB, and coactivators
@nl
P2093
P2860
P3181
P356
P1476
Interaction of the COOH-termin ...... n factor IIB, and coactivators
@en
P2093
M L Schmitz
M Meisterernst
P A Baeuerle
P2860
P304
P3181
P356
10.1074/JBC.270.13.7219
P407
P577
1995-03-31T00:00:00Z